DreamCIS Inc (223250.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Services · South Korea · ISIN KR7223250002
DreamCIS Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 58.65 bn KRW | 66.63 bn KRW |
| Gross profit | 17.86 bn KRW | 19.38 bn KRW |
| Operating income | 5.06 bn KRW | 5.24 bn KRW |
| EBIT | 6.38 bn KRW | 11.21 bn KRW |
| Net income | 5.28 bn KRW | 7.13 bn KRW |
| Diluted EPS – continuing operations | 221.86 KRW | – |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.
More stocks
- Jingbo Technology, Inc. (SVMB)
- PEH Wertpapier AG (PEH.F)
- Global Asset Management Group, Inc. (GAMG)
- Airship AI Holdings, Inc. (AISP)
- OCONEE FINANCIAL CORP (OSBK)
- Canyon Resources Ltd (CAY.AX)
- Hydrogen Freehold & Leasehold Real Estate Investment Trust (HYDROGEN.BK)
- Vuno Inc. (338220.KQ)
- Crystalvue Medical Corporation (6527.TWO)
- Arbe Robotics Ltd (ARBE)
- Freja eID Group AB (FREJA.ST)
- Kraft Bank Asa (KRAB.OL)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.